Showing results (21-30 of 3,882) with videos related to
Sort By:
Pageof 389
Expert Opinion on Investigational Drugs|January 4, 2011
Vorinostat in acute myeloid leukemia and myelodysplastic syndromesThomas Prebet, Norbert VeyExpert Opinion on Investigational Drugs|December 2, 2010
Emerging small molecule and biological therapeutic approaches for the treatment of autoimmunityAndrew J Leishman, Gary P Sims, Matthew Sleeman, et al.Expert Opinion on Investigational Drugs|November 19, 2010
Farnesyltransferase inhibitors: where are we now?Apostolia Maria Tsimberidou, Chandtip Chandhasin, Razelle KurzrockExpert Opinion on Investigational Drugs|December 1, 2010
Aleglitazar, a balanced PPARα/γ agonist, has no clinically relevant pharmacokinetic interaction with high-dose atorvastatin or rosuvastatinAdam J Foley-Comer, Anne-Marie Young, Fiona Russell-Yarde, et al.Expert Opinion on Investigational Drugs|November 12, 2010
Dimethyl fumarate for multiple sclerosisAthina Papadopoulou, Marcus D'Souza, Ludwig Kappos, et al.Expert Opinion on Investigational Drugs|November 12, 2010
Clinical pharmacology study of the corticosteroid nasal spray dexamethasone cipecilate (NS-126): examination of the durability of efficacy in the nasal induction testMinoru Gotoh, Kimihiro Okubo, Minoru Okuda, et al.Expert Opinion on Investigational Drugs|June 5, 2010
Future novel therapeutic agents for Clostridium difficile infectionHoonmo L Koo, Kevin W Garey, Herbert L DupontExpert Opinion on Investigational Drugs|May 15, 2010
Therapeutic potential and limitations of new FAK inhibitors in the treatment of cancerAlexander Schultze, Walter FiedlerExpert Opinion on Investigational Drugs|May 15, 2010
BIBF 1120 for the treatment of non-small cell lung cancerMartin ReckExpert Opinion on Investigational Drugs|September 18, 2010
Akt inhibitors in clinical development for the treatment of cancerSumanta Kumar Pal, Karen Reckamp, Hua Yu, et al.Pageof 389